Formulation Development
FORMULATION DEVELOPMENT WHITE PAPERS & ARTICLES
-
How To Capture Growth In The Expanding Metabolic Drug Market
Driven by GLP-1 success and rising obesity rates, R&D investment in metabolic disease therapies now rivals oncology, demanding rapid development to overcome market challenges.
-
What's Next In Pharmaceutical R&D?
Emerging R&D trends focus on novel pulmonary and nasal delivery methods. Solubility remains a key challenge, addressed through techniques like microfluidics for nanosuspensions.
-
How One Biotech Company Is Accelerating The Drug Discovery Workflow
See how biotech innovation is accelerating drug discovery through AI, miniaturized workflows, and collaborative technologies to reshape how therapies are developed and delivered.
-
Advanced Therapies Going Mainstream: Are We There Yet?
Advanced therapies are nearing mainstream adoption, with cell, mRNA, and oligonucleotide treatments expanding into broader indications. Learn what’s driving this shift and what manufacturers must do.
-
Patient-Centric Formulations In Pediatric Adherence
Improving pediatric adherence requires age-appropriate formulations, taste-masking, and swallowability strategies. Regulatory, clinical, and technological insights help overcome barriers and support safer, more effective therapies for children across developmental stages.
FORMULATION DEVELOPMENT APPLICATIONS & STUDIES
-
Cell Culture Media Mixing In A Benchtop Single-Use Mixer
Explore how efficient powder-liquid mixing and sterile filtration preserve media integrity and support reproducibility in biopharmaceutical workflows, with promising scalability for larger-volume applications.
-
Assessing Particle Generation In A Single-Use Mixing System
Explore how particle levels remained stable during 24 hours of high-speed mixing, even under extreme temperatures, confirming a system’s suitability for final fill and other particulate-sensitive applications.
-
Your Guide To Precise And Robust Separation Methods
Discover a detailed guide to characterizing GLP-1 receptor agonists that covers advanced LC-MS and SEC-MALS workflows for impurity profiling, stability testing, and aggregate analysis.
-
Simplify Cell Line Development
A streamlined workflow combining microfluidic dispensing and multimodal imaging enables efficient single-cell isolation, viability assessment, and outgrowth analysis to support cell line development.
-
A Universal Workflow Approach For Single Cell Mass Spectrometry Based Proteomics
Learn about a streamlined workflow that improves reproducibility, reduces contamination, and simplifies single-cell proteomics with comparable results to FACS.
FORMULATION DEVELOPMENT SOLUTIONS
- LC And LC-MS Chemistry Consumables For Bioseparations
- Largest Global Network Of Harmonized GMP Product Testing Laboratories
- Control Your Bioprocess Development: Faster Decisions With Quality Data
- Capacity To Secure Your Success
- API Stability Combined With Rapid Disintegration
- Chromatography Consultation Tools For Process Intensification
- High-Content Screening System
- Speed, Scale, And Supply With Innovative Cell Culture Solutions
- Designed For Inhalation: Pulmonary And Nasal Delivery
- Guarantee A Successful Expansion With An Organoid Expansion Service
PHARMACEUTICAL AND FORMULATION DEVELOPMENT NEWS
- Bora Pharmaceuticals And Corealis Pharma Forge Strategic Alliance To Deliver Seamless, End-To-End Oral Solid Dose Development
- Marchesini Group And AST Unite To Expand Global Sterile Fill-Finish Capabilities
- Late-Model Lab & Bioprocess Equipment From Premier Biopharma Facility To Be Offered For Sale December 4–9, 2025
- Bora Pharmaceuticals Marks Five Years In Mississauga, Canada, Strengthening Its Commitment To Onshore And Global CDMO Excellence
- Techceuticals Announces 2026 Solid Dosage Manufacturing Process Training Schedule
- Quotient Sciences And Intrepid Labs Form Strategic Partnership To Accelerate AI-Guided Formulation Development
- Large-Capacity Double Planetary Mixer Ideal For Highly Viscous Materials
- CSL To Build Out U.S. Plasma Capabilities Through $1.5B Investment
- Equipment Auction Announced For Sutro Biopharma Assets
- Syntegon Delivers Strong Growth And Margin Expansion In Q3 2025 With Accelerating Pharma Momentum And Profitability Gains Across All Segments